Third Arc Bio
Nicholas Delatorre is a skilled Senior Scientist specializing in CMC at Third Arc Bio since January 2025, following a previous role as Scientist II at Asimov from September 2021 to January 2025. During tenure at Asimov, Nicholas developed CHO cell culture processes and presented research at Cell UK. Prior experience includes positions at Biogen, where Nicholas improved bioprocessing methods for monoclonal antibodies, and Lyndra Therapeutics, focusing on biodegradable materials for drug delivery systems. Nicholas has also contributed to research at Northeastern University and various internships, acquiring extensive knowledge in biopharmaceutical development, process optimization, and innovative project management throughout a career that began with a Bachelor of Science in Chemical Engineering from Northeastern University in 2017.
This person is not in the org chart
This person is not in any teams
Third Arc Bio
Third Arc Bio is a biotech company developing multifunctional antibodies that generate immune synapses that precisely activate or inhibit T cells. The company’s drug development engine delivers superior biologics optimized to create best-in-class T cell engagement by leveraging two technologies that power a pipeline of high value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. To learn more, visit www.thirdarcbio.com.